Top medtech deals of H1 2026 highlight M&A activity and strategic shifts
The first half of 2026 saw significant mergers and acquisitions in the medical technology sector, with over $36.5 billion in deal value reported by PwC. Key transactions included Boston Scientific's acquisition of Penumbra for $14.5 billion to expand into thrombectomy markets and Danaher’s purchase of Masimo for $9.9 billion.
Topics: Boston Scientific Danaher Masimo MedTech Mergers & Acquisitions Penumbra